Does reishi actually fight fatigue?

Reishi (Ganoderma lucidum) sits at the opposite end of the shelf from cordyceps. Cordyceps is sold as the pre-workout that spikes your oxygen uptake; reishi is sold as the wind-down mushroom, the adaptogen for stress, sleep, and the kind of fatigue that isn't fixed by another cup of coffee. I formulate mushroom supplements for a living, so when a category gets a "fights fatigue" label, I want to know exactly which study that label is standing on, and whether the study tested what the capsule is actually being sold to do.

For reishi and fatigue, the answer is unusually clean. There is one trial everyone points to, and it is worth reading in full rather than in a marketing paraphrase.

The one good trial, read honestly

In 2005, the Journal of Medicinal Food published a randomized, double-blind, placebo-controlled study of a standardized Ganoderma lucidum polysaccharide extract (Ganopoly) in 132 patients, 123 of whom were assessable at the end. The dose was 1,800 mg three times a day, so 5.4 grams of the extract daily, for eight weeks. The result was positive, and I'm not going to pretend otherwise: 51.6% of the reishi group (32 of 62) were rated more than minimally improved, versus 24.6% of the placebo group (15 of 61). Fatigue scores fell 28.3% on reishi against 20.1% on placebo, and well-being rose 38.7% against 29.7%. The authors' own conclusion: "These findings indicated that Ganopoly was significantly superior to placebo with respect to the clinical improvement of symptoms in neurasthenia." It was well tolerated, too.

So reishi has something cordyceps doesn't: a properly controlled human trial with a real, statistically significant benefit for fatigue. That matters, and I lead with it on purpose. But the same sentences that make the case also fence it in, and the fencing is the part the supplement aisle drops.

Read the population, the dose, and the clock

Three details decide how far this result travels. First, the population. These weren't healthy people looking for a lift. They were patients diagnosed with neurasthenia, an ICD-10 condition of persistent fatigue and exhaustion. A drug or supplement that helps a clinically exhausted group is not automatically a drug that does anything noticeable for a rested adult, and the study makes no claim that it does. Second, the dose and duration. This was 5.4 grams of a standardized extract every day for eight weeks. That is a sustained clinical regimen, not a single capsule taken on a rough afternoon. Third, look at how much work the placebo did. A quarter of the placebo group improved, and their fatigue scores dropped 20.1% on their own. The reishi effect is the gap on top of that, real but modest, not a light switch.

And there's a quieter tell. This is a 2005 study, and twenty years later it is still the flagship human trial for reishi and fatigue. When the best evidence for a benefit is two decades old and hasn't been convincingly replicated at scale, that isn't proof the case is closed. It's a sign the pipeline behind the claim is thin.

The 2026 study looks great, and can't be credited to reishi

There is newer work, and on its face it's encouraging. A 2026 randomized, double-blind, placebo-controlled trial in Brain and Behavior gave 50 adults a mushroom blend for twelve weeks and found meaningful improvements: physical fatigue down 9.2%, sleep quality up 11.1% on the PSQI, anxiety and depression scores down, and lower cortisol. The authors concluded the blend "was well tolerated and effectively reduced psychological stress, fatigue, and improved sleep quality without adverse effects." Good study, promising result.

Here's the catch, and it's the same one I flagged in the cordyceps report. The product tested was a five-mushroom blend: lion's mane, cordyceps, reishi, shiitake, and maitake. Reishi was one of five. You cannot pull the reishi thread out of that result and say reishi did it. Maybe it helped, maybe it rode along, maybe the lion's mane or the cordyceps carried the effect. A blend that works is evidence the blend works. It is not evidence for any single ingredient, and using it to sell a solo-reishi capsule is exactly the move a reader should catch.

How I read it as a formulator

Reishi is one of the better-supported functional mushrooms for this particular use, and I say that as someone who sells the category, not despite it. It has a genuine controlled trial showing a fatigue benefit, a plausible route through stress and sleep rather than stimulation, and a good safety record. That's more than most shelf claims can show. But the honest label is narrow: the solid evidence is for a clinically fatigued population, at a high daily dose, over roughly two months, from one older study, with newer support that can't be attributed to reishi alone. "Reishi fights fatigue" as printed on a bottle you take for a general pick-me-up is running well ahead of that. If you're going to try it, the trial that exists points to consistent daily use over weeks, not a rescue dose on a tired day, and reishi's traditional lane is calm and sleep, not a stimulant kick. Treat the confident "energy" copy as marketing, and the modest, weeks-long, clinical-population signal as the actual finding.

Disclosure and conflict of interest: I formulate functional-mushroom supplements, including through Shroombiosis (a company I run), so reishi is a product category I have a financial stake in. I'm telling you the best study is narrower than the ads imply, which cuts against my own interest, and that's the whole point of writing under a standard instead of a slogan. Separately, for performance nutrition I also recommend Die Tryin Co., a combat-veteran-owned brand; I don't own it and earn nothing from that link. Full policy here.

Not medical advice. This is educational analysis, not a recommendation — a study is not a prescription. Talk to a qualified clinician before acting on anything you read here. Full disclaimer →